Complete reversal of left ventricular mass in FIP1L1-PDGFRA-positive chronic eosinophilic leukemia after therapy with imatinib.
作者信息
Volz Hans C, Weiss Celine, Lossnitzer Dirk, Zankl Alexandra R, Perz Jolanta B, Dengler Thomas J, Katus Hugo A, Hardt Stefan E
出版信息
Int J Cardiol. 2011 Sep 15;151(3):e90-2. doi: 10.1016/j.ijcard.2010.06.003. Epub 2010 Jul 6.
PMID:20609486
Abstract
摘要
相似文献
1
Complete reversal of left ventricular mass in FIP1L1-PDGFRA-positive chronic eosinophilic leukemia after therapy with imatinib.伊马替尼治疗后FIP1L1-PDGFRA阳性慢性嗜酸性粒细胞白血病患者左心室质量完全逆转。
Int J Cardiol. 2011 Sep 15;151(3):e90-2. doi: 10.1016/j.ijcard.2010.06.003. Epub 2010 Jul 6.
2
Pure red cell aplasia associated with imatinib-treated FIP1L1-PDGFRA positive chronic eosinophilic leukemia.与伊马替尼治疗的FIP1L1-PDGFRA阳性慢性嗜酸性粒细胞白血病相关的纯红细胞再生障碍
Intern Med. 2010;49(12):1195-200. doi: 10.2169/internalmedicine.49.3178. Epub 2010 Jun 15.
3
Rapid reversion of eosinophilic gastroenteritis associated with FIP1L1-PDGFRA fusion after targeted therapy with imatinib.伊马替尼靶向治疗后，与FIP1L1-PDGFRA融合相关的嗜酸性粒细胞性胃肠炎迅速逆转。
Br J Haematol. 2006 Jan;132(2):123. doi: 10.1111/j.1365-2141.2005.05698.x.
4
Weekly imatinib dosage for chronic eosinophilic leukaemia expressing FIP1L1-PDGFRA fusion transcript: extended follow-up.用于表达FIP1L1-PDGFRA融合转录本的慢性嗜酸性粒细胞白血病的伊马替尼每周剂量：长期随访
Br J Haematol. 2009 Apr;145(1):132-4. doi: 10.1111/j.1365-2141.2008.07546.x. Epub 2008 Dec 20.
5
Cessation of imatinib mesylate may lead to sustained hematologic and molecular remission in FIP1L1-PDGFRA-mutated hypereosinophilic syndrome.甲磺酸伊马替尼的停药可能导致FIP1L1-PDGFRA突变的嗜酸性粒细胞增多综合征出现持续的血液学和分子学缓解。
Am J Hematol. 2014 Jan;89(1):115. doi: 10.1002/ajh.23588. Epub 2013 Oct 15.
6
FIP1L1-PDGFR alpha, a therapeutic target for the treatment of chronic eosinophilic leukemia.FIP1L1-PDGFRα，一种用于治疗慢性嗜酸性粒细胞白血病的治疗靶点。
Verh K Acad Geneeskd Belg. 2005;67(3):169-76.
7
Detection of FIP1L1-PDGFRA fusion by FISH.通过荧光原位杂交检测FIP1L1-PDGFRA融合基因。
Br J Haematol. 2007 Aug;138(3):279. doi: 10.1111/j.1365-2141.2007.06637.x. Epub 2007 Jun 3.
8
[Efficacy of imatinib in FIP1L1-PDGFRA positive hypereosinophilic syndrome].伊马替尼治疗FIP1L1-PDGFRA阳性高嗜酸性粒细胞综合征的疗效
Rev Med Interne. 2008 Jan;29(1):65-7. doi: 10.1016/j.revmed.2007.09.036. Epub 2007 Oct 25.
9
10
Low-dose imatinib mesylate leads to rapid induction of major molecular responses and achievement of complete molecular remission in FIP1L1-PDGFRA-positive chronic eosinophilic leukemia.低剂量甲磺酸伊马替尼可迅速诱导FIP1L1-PDGFRA阳性慢性嗜酸性粒细胞白血病出现主要分子反应并实现完全分子缓解。
Blood. 2007 Jun 1;109(11):4635-40. doi: 10.1182/blood-2006-10-050054. Epub 2007 Feb 13.
Zotero 插件